SEC Form 5 · accession 0001547522-15-000025
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vicki Jones
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Feb 10, 2015 | J | 190,000 | $0.526 | A | 796,589 | I | Held by Spouse |
| Common stock | holding | — | — | — | 606,589 | I | Held by Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from the CEO of the Company as part of a settlement agreement.